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Abstract
OBJECTIVES: Many intraoperative decisions regarding the extent of thoracic aortic surgery are subjective and are based on the
appearance of the aorta, perceived surgical risks and likelihood of early recurrent disease. Our objective in this work was to carry out a
cross-sectional study to demonstrate that rapid evaporative ionization mass spectrometry (REIMS) of electrosurgical aerosol is able to
empirically discriminate ex vivo aneurysmal human thoracic aorta from normal aorta, thus providing supportive evidence for the
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METHODS: Human aortic tissue was obtained from patients undergoing surgery for thoracic aortic aneurysms (n = 44). Normal
aorta was obtained from a mixture of post-mortem and punch biopsies from patients undergoing coronary surgery (n = 13). Monopolar
electrocautery was applied to samples and surgical aerosol aspirated and analysed by REIMS to produce mass spectral data.
RESULTS: Models generated from REIMS data can discriminate aneurysmal from normal aorta with accuracy and precision of 88.7% and
85.1%, respectively. In addition, further analysis investigating aneurysmal tissue from patients with bicuspid and tricuspid aortic valves was
discriminated from normal tissue and each other with accuracies and precision of 93.5% and 91.4% for control, 83.8% and 76.7% for
bicuspid aortic valve and 89.3% and 86.0% for tricuspid aortic valve, respectively.
CONCLUSIONS: Analysis of electrosurgical aerosol from ex vivo aortic tissue using REIMS allowed us to discriminate aneurysmal from
normal aorta, supporting its development as a point-of-care test (Intelligent Knife) for guiding surgical intraoperative decision-making.
Keywords: Thoracic aortic aneurysm • Rapid evaporative ionization mass spectrometry • Bicuspid aortic valve • Tricuspid aortic valve
ABBREVIATIONS
BAV Bicuspid aortic valve
i-knife Intelligent Knife
NHS-BT NHS blood and transplant service
PLS-DA Partial least squares-discriminant analysis
REIMS Rapid evaporative ionization mass spectrometry
ROC Receiver operating curve
TAV Tricuspid aortic valve
TIC Total ion current
VIP Variable importance of projection
INTRODUCTION
Indications for surgery on thoracic aortic aneurysms are well
described in European and American Society Guidelines [1, 2] and
are heavily weighted towards symptomology and cross-sectional
dimensions. Many intraoperative decisions regarding the extent of
thoracic aneurysm surgery are subjective and are based on the ap-
pearance of the vessel (including subjective assessment of the an-
eurysm size, aortic wall thickness and appearance of the tunica
media), perceived surgical risks and likelihood of early recurrent
disease. To date, technological innovation has not provided an
intraoperative point-of-care test, which helps guide these decisions,
which may have significant consequences for patients if incorrect.
Recent advances in oncological surgery have shown the utility of
analysing electrosurgical aerosol with rapid evaporative ionization
mass spectrometry (REIMS) or so-called ‘Intelligent Knife’ (i-knife),
in guiding surgeons on tumour resection margins [3]. The tech-
nique involves intraoperative mass spectrometric analysis of tissue
diathermy fumes which provides an empirical measure of normal
versus tumour cells. Our objective is to share our preliminary data
from using REIMS to analyse ex vivo normal and aneurysmal
human aortic tissue, and comparison to previously reported sup-
portive biomechanical and biochemical variables, as a prelude to
intraoperative human studies.
METHODS
Tissue and patient characteristics
Aortic tissue samples were obtained from patients undergoing
elective proximal thoracic aortic surgery with aneurysmal path-
ology at Liverpool Heart and Chest Hospital between 2016 and
2019. Control tissues were obtained from patients undergoing
elective coronary artery bypass surgery at Liverpool Heart and
Chest Hospital or snap frozen cadaveric samples from National
Health Service Blood and Transplant service (NHS-BT). All tissue
was stored at -80C prior to testing. As this was a preliminary inves-
tigation study size was determined by tissue availability at time of
study. Tissue samples originated from the root and ascending aorta,
the nature of the leaflet configuration of the aortic valve was noted.
Patients with known syndromic connective tissue disorders, aortic
dissection or atherosclerotic aneurysms were excluded from the
study. Tissue from surgery was frozen in super-cooled liquid nitro-
gen immediately after collection. Surgical patient demographic and
clinical characteristics were stored in hospital Electronic Patient
Records, age and gender information for the cadaveric tissue was
obtained from NHS-BT records. The study was ethically approved
by Liverpool Bio-Innovation Hub (project approval references 15-
06 and 19-09). The study conformed to the principles outlined in
the Declaration of Helsinki and followed Strengthening the
Reporting of Observational Studies in Epidemiology) guidelines.
Informed consent was obtained for all participants. Cadaveric sam-
ples were removed from donors for transplant but not subsequent-
ly utilized for this purpose for various reasons. Consent was
obtained to use this tissue for research with National Research
Ethics Service approval (REC Reference 11/EE/0528).
REIMS
Tissue samples were thawed and a 5-mm punch removed and
placed onto glass microfiber paper (GFP, GE Healthcare
Whatman). Samples were wetted with 100ml of milli Q water
(Merck Millipore). Sampling used a monopolar diathermy elec-
trosurgical pencil (Erby Medical UK LTD, Leeds) (i-knife). A power
of 35 W was applied across the tissue punch at room tempera-
ture, and the aerosol was aspirated and directed into the REIMS
source (Waters, UK). At the same time, a lockmass solution of
5 pmol/ml leu-enkephalin in propan-2-ol at a flow rate of 50ml/min
was delivered to the REIMS source attached to a Synapt G2-Si
(Waters, UK) in resolution mode. Spectra were recorded in negative
ion mode from m/z 50 to 1200 at a scan rate of 1 Hz. Burn events
lasted from 10 to 30 s. To avoid pseudoreplication caused by seg-
mentation of burn events, the raw data were first processed using
Progenesis Bridge to convert any uneven burn events into a single
pseudo-Gaussian [time, total ion current (TIC)]. TIC is the cumula-
tive effect of ions hitting the detector regardless of m/z throughout
a single scan event, i.e. the sum of all m/z intensities of the spectra
at the specific scan. The processed TIC trace was always 35 scans
across, with the burn event covering 12 scans reaching a maximum
at scan 18. This processed TIC trace was then imported into LiveID
ensuring that there was only one datum per burn event in all
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subsequent analysis. Where sufficient tissue was available, samples
were subject to 2 REIMS analyses on different days.
Data processing and statistical analyses
Raw data were pre-processed using Progenesis Bridge, a feature
within the MassLynx Software (Waters, Manchester), with a
threshold of 0, to normalize the TIC trace and combine the burn
events enabling the comparison of a single spectrum from each
punch. Data were binned with an m/z window of 0.01 and data
matrix exported.
All data transformations and modelling were undertaken in the
statistical software R [4] with graphical representations using the
packages rgl [5], ggplot2 [6] and ggpubr [7]. Zero values were
replaced for very small positive numbers to avoid indeterminacy
calculations (i.e. 10-8). Data were log transformed and Pareto scaled.
Partial least squares-discriminant analysis (PLS-DA) models were
used to determine the suitability of REIMS data to predict different
aetiologies as well as select relevant features with predictive capabil-
ities. PLS-DA models were created using the package mixOmics [8].
Data were split in 80/20 proportions for training/test. The training
data were used to build a PLS-DA model. The number of compo-
nents chosen for the model was determined using a two-fold cross-
validation and choosing the number of components that minimize
the misclassification error. The test data were used to assess the
model and calculate accuracy, sensitivity, recall and f1 for the
model (see Supplementary Material for definitions of these terms).
Important features of the models were extracted and reported [vari-
able importance projection (VIP) plots]. This process was repeated
50 times generating 50 models with average accuracy and sensitiv-
ity reported. A second model was created in the same manner by
selecting a subset of data based on m/z values with a VIP mean and
median of >1. Representative score plots and model accuracies are
reported in the results section. Receiver operating characteristic
(ROC) and area under the curve were used to provide graphical
representation of the model diagnostics. They were calculated
based on the predicted scores obtained from the models on the
test data. For each class the prediction is made of the class itself ver-
sus the others, allowing more than binary models to be appraised.
RESULTS
Control and aneurysmal tissues can be
discriminated using REIMS
An overview of the experimental data collection, data processing
and analyses is shown in Fig. 1. Table 1 shows clinical characteris-
tics for all patients. Cohorts had no significant difference in age
(P = 0.67), or indexed size for aneurysmal cohorts (P = 0.15).
REIMS data were collected from aortic tissue for control (n = 13)
and aneurysm (n = 44) patients over 2 separate days with patients
analysed on both days if sufficient tissue was available. Variability
between multiple samples from the same patient was minimal
compared with variability between patient samples as can be
seen in Supplementary Material, Fig. S1. Datasets were combined
ensuring that all patients were only represented once.
An initial round of modelling was carried out using 11 500 m/z
values. This resulted in 2 component models that were able to
discriminate between control and aneurysm patient tissues with
85.8% mean accuracy and 78.9% mean precision (Supplementary
Material, Table S1). To improve the models further, important
features of the models (VIPs) with mean and median score larger
than 1 were selected for a second round of modelling (see Fig. 1).
This generated a model that included 3236 m/z values and
was able to discriminate patients with improved accuracy of
88.7% and precision 85.1% (Supplementary Material, Table S2).
A representative score plot is shown in Fig. 2A accompanied by
the accompanying ROC curve (Fig. 2B). Full model statistics
for both models are reported in Supplementary Material,
Tables S1 and S2. Interrogation of the models generated showed
that gender (Supplementary Material, Fig. S2A) or source of con-
trol tissue (Supplementary Material, Fig. S2B) were not contribu-
ting to the observed discrimination.
Figure 1: Workflow for the study. Aortic tissue was obtained during aortic replacement surgery or from post-mortem tissue for control (n = 13) or aneurysm patients
(n = 44). Rapid evaporative ionization mass spectrometry data were acquired over 2 days with samples measured on both days (where sufficient tissue was available)
to test intra- and inter-sample reproducibility (see Supplementary Material, Fig. S1). A merged dataset was produced with 50% of samples from each rapid evapora-
tive ionization mass spectrometry dataset. Partial least squares-discriminant analysis modelling was performed and tested using randomly generated training (80%)
and test (20%) data (round 1). Important features of the models were extracted (variable importance of projections) and variables selected from these for further mod-
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Aneurysmal aortic tissues derived from patients
with bicuspid and tricuspid valves can be
discriminated using REIMS
Following this initial assessment, aneurysm patients were sub-
divided according to their aortic valve morphology into bicuspid
aortic valve (BAV) (n = 21) and tricuspid aortic valve (TAV)
(n = 23) cohorts and the modelling process repeated. PLS-DA
models to discriminate between control, BAV and TAV resulted
in 3 component models. The models from round 1, built using
11 500 m/z values resulted in mean accuracies of 81.3%, 57.0%
and 70.3% and mean precision values of 68.8%, 40.0% and 67.3%
for the discrimination of control, BAV and TAV tissues from the
other groups, respectively (Supplementary Material, Table S3).
A tota of 3351 m/z variables with a mean and median VIP score
of larger than 1 were selected for a second round of modelling.
A representative score plot for one of the models is shown in
Fig. 3. An additional 2D plot showing 2 of the 3 components
Table 1: Aortic pathology and summary patient clinical characteristics grouped by clinical condition collated from electronic patient
records and NHS blood and transplant service records
Control BAV TAV
Pathology: aetiology
Normal: coronary artery disease/healthy post-mortem tissue (n) 4/9
Aneurysm: bicuspid aortic valve (n) 21
Aneurysm: tricuspid aortic valve (n) 23
Age (years), median (IQR) 67 (19) 66 (7) 72 (15)
Sex
Male (n) 9 12 12
Female (n) 4 9 11
Indexed aorta size, median (IQR) – 11.5 (3.0) 13.2 (8.0)
Diabetic 0/4 0/21 1/23
Hypertensive 3/4 13/21 17/23
Hypercholesterolemia 3/4 11/21 17/23
Family history of aneurysm 0/4 3/21 3/23
Indexed aorta size is not available for control patients. Clinical characteristics for control patients reflect CABG patients only as this information is not available for
NHS-BT tissue. Quantitative values are expressed as median and interquartile range (IQR).
BAV: bicuspid aortic valve; CABG: coronary artery bypass graft; NHS-BT: NHS blood and transplant service; SD: standard deviation; TAV: tricuspid aortic valve.
Figure 2: Partial least squares-discriminant analysis representative model for rapid evaporative ionization mass spectrometry data between control (n = 13) and aneur-
ysm patients (n = 44). (A) Score plot of the two-component model. Points represented for both training (circles) and test (triangles) for both groups control (cyan) and
aneurysm (red) with ellipse representative of the 95% region around the means of each group. It is clear that the groups can be separated with this model. (B)
Receiver operating curve of the model representing an area under the curve value of 0.963. Fifty models were fitted with average statistics reported in Supplementary
Material, Table S2.
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indicating training and test data and accompanying ROC curve
is shown in Supplementary Material, Fig. S3. The mean accura-
cies of this model increased to 93.5%, 83.8% and 89.3% and
mean precision values increased to 91.4%, 76.7% and 86.0%
for control, BAV and TAV, respectively. All values for model
assessment are reported in Supplementary Material, Tables S3
and S4, with area under the curve assessment reported in
Supplementary Material, Table S5. Hence, the techniques
are able to discriminate tissues from patients with various
cardiovascular aetiologies.
DISCUSSION
REIMS coupled with a diathermy (i-knife) has the potential to
aide to surgical decision-making in aortic surgery. The principles
of the technique are that surgical aerosol emanating from elec-
trocautery and destruction of tissues is aspirated into a mass
spectrometry producing a signal by measuring the mass to
charge ratio of molecular ions and their charged fragments [9].
REIMS has been explored in a number of clinical [10, 11] and
non-clinical [12–14] areas; however, i-knife is currently being
explored, and has achieved some notoriety, as an aide to identi-
fying tumour margins in breast surgery [3]. We have hypothesized
that REIMS may be of use in aortic surgery by providing some
objectivity to the subjective intraoperative decision-making com-
monly required in the management of borderline aneurysms. As
a preliminary explorative approach, we conducted batch labora-
tory REIMS analysis of aortic tissue from patients which included
normal and aneurysmal proximal aorta (ascending aorta). Our
methodology was able to clearly discriminate aneurysmal aorta
from normal aorta (Fig. 2) with accuracy of 88.7% and precision
of 85.1%. We have previously reported differences in biomechan-
ical and biochemical properties of aortic tissue between normal,
BAV and TAV [15–17]. We have also observed distinct patterns of
matrix degradation in aortic tissue between the 3 groups [15].
Detailed assessment of histological staining identified a decrease
in elastin content across all 3 layers of the aortic wall that fol-
lowed the trend; control > BAV > TAV. In addition, we found that
TAV patient tissue had highly fragmented elastin with thinner
elastic lamellae compared to BAV and control. Other studies
have also shown altered matrix architecture for aneurysmal tissue
[18, 19] with a similar trend of BAV fibre orientation more similar
to control tissue than TAV [20]. The current study compares tissue
from patients with the same aortic pathologies used in these
previous studies and shows that REIMS can discriminate aortic
tissue from the 3 patient cohorts (Fig. 3). While the 3D model
can clearly discriminate between the 3 aetiologies, we can see
that in 2 dimensions TAV and controls have the most differences
while BAV tissue properties seem to sit in the interphase of both
clusters (Supplementary Material, Fig. S3), consistent with previ-
ously reported histological observations [15]. This observation
could explain why precision and accuracy values discriminating
BAV from other pathologies are lower (83.8% and 76.7%, respect-
ively) than those for control (93.5% and 91.4%, respectively) or
TAV (89.3% and 86.0%, respectively).
All of the techniques utilized in previous studies highlighted
above require ex vivo tissue and are often time-consuming proc-
esses and can detect a very limited number of variables at a time.
Here, we show that REIMS can discriminate between control,
and BAV and TAV aneurysmal tissue with excellent accuracy and
precision. REIMS generates data virtually instantaneously, within
seconds making it ideally suited for intraoperative use without
causing a delay to the operating procedure. We therefore
propose REIMS as a near real-time technique with potential as a
future point-of-care technique (Fig. 4). The guidance for surgical
intervention on the thoracic aorta is dominated by preoperative
imaging measurements with adjustments for syndromic disease,
symptomology and concomitant cardiac disease [1, 2]. In reality,
final decisions on resection or the longitudinal extent of resection
are based on the subjective decisions of the surgeon. In non-
syndromic aneurysms the most significant extent of a proximal
aneurysm is principally the ascending aneurysm. In borderline
proximal and distal disease, decisions are made on the risk of
extending the resection to include the aortic root and proximal
aortic arch versus the risk of early recurrent disease. This will be
based on factors such as patient age, comorbidity and frailty
but also on the surgeon’s opinion on the appearances of the
aorta, the thinness of the wall and the lamination of the media.
Such decisions have significant consequences and to-date
are based on a surgeon’s experience, with few, if any, options for
objective measures.
Our intention is to conduct future studies including a
systematic prospective study of ex vivo fresh aorta examining the
longitudinal REIMS signal from normal, borderline and aneurys-
mal aorta, indexed to body surface area along with a mechanistic
study examining REIMS signal and aetiology of aneurysmal for-
mation. Using this approach, intraoperative data obtained in
near real-time (seconds) could be employed to guide surgeons
on the extent of resection required at the margins on patients
with borderline aneurysmal ascending aorta and in other inter-
ventions including valve and coronary surgery.
Currently REIMS technology is not commercially available for
clinical application and remains in development. The diathermy
is comparable with a typical electrosurgical tool. However, the
attached mass spectrometer would require situating in an adja-
cent room with a computer monitor in theatre to report the
results. Therefore, the hardware needs miniaturizing and com-
mercializing. This study is based on laboratory analysis of ex vivo
aorta; however, other oncological studies have shown that it may
pragmatically be deployed in the operating theatre. Our hope is
that future studies will allow us to deploy this REIMS, and other
Figure 3: Partial least squares-discriminant analysis representative model 3D
plot for rapid evaporative ionization mass spectrometry data between control,
bicuspid aortic valve and tricuspid aortic valve patients. Three-component
model generated, each patient is represented as a circle for control (green,
n = 13), bicuspid aortic valve (red, n = 21) and tricuspid aortic valve (blue,
n = 23), with ellipse representative of the 95% region around the means of each
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spectroscopic methods such as Raman spectroscopy in the
operating room, recording in vivo measurements.
Limitations
There were several limitations to this study. First, analysis was
carried out retrospectively following freezing, storage and
thawing of tissue. Future studies should aim to conduct in vivo
analysis. Second, normal or control aorta was a mixture of punch
biopsy from patients undergoing coronary artery by-pass graft
and post-mortem tissue from NHS-BT. However, no statistical
differences were observed during data analysis between these 2
different sources enhancing our confidence that differences be-
tween control and aneurysmal tissue were not due to differences
in storage or tissue collection processes. Third, we have not
systematically sampled longitudinally from ‘normal’, ‘borderline’
or ‘peri-aneurysmal penumbra’ and aneurysm. This is required as
the next stage in technique development. Fourth, patients
with connective tissue disorders were excluded from the study.
In future, other pathologies (Marfan, Loeys–Dietz syndrome,
Ehlers–Danlos syndrome) will be addressed systematically with
the aim of producing a library of biosignatures. Fifth, we have
not determined the origin/identity of the key spectrometry sig-
nals (VIPs) within this study. The latter remains one of the caveats
of this technique: there are very limited and poorly annotated
database entries or software to undertake signal identification.
CONCLUSION
Analysis of electrosurgical aerosol from ex vivo aortic tissue using
REIMS allows us to discriminate aneurysmal from normal aorta
and sub-divide patients with different valve sub-types, supporting
its development as a point-of-care test (i-knife) for guiding
surgical intraoperative decision-making.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
DATA AVAILABILITY
Raw or processed REIMS data are available upon request to the
corresponding author.
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[8] Rohart F, Gautier B, Singh A, Lê Cao K-A. mixOmics: an R package for
‘omics feature selection and multiple data integration. PLoS Comput Biol
2017;13:e1005752.
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